Abstract:BackgroundHigh-density lipoproteins (HDLs) can exert anti-atherogenic effects. On top of removing excess cholesterol through reverse cholesterol transport, HDLs play beneficial actions on endothelial function and integrity. In particular, HDLs are strong determinant of endothelial progenitor cells (EPCs) number and function. To gain further insights into such an effect we characterized in vitro functionality of circulating “early” EPCs obtained from 60 type 2 diabetes individuals with low HDL-cholesterol (HDL-C) and 59 with high HDL-C levels.MethodsAfter an overnight fast, venous blood was drawn in EDTA tubes and processed within 2-h from sampling. Peripheral blood mononuclear cells were isolated and plated on fibronectin coated culture dishes; after 3 days culture, adherent cells positive for Dil-ac-LDL/Lectin dual fluorescent staining were identified as monocytic angiogenic cells (MACs). After 5–7 days culture in EBM-2 medium, adherent cells were evaluated for viability/proliferation (MTT assay), senescence (beta-galactosidase activity detection), migration (modified Boyden chamber using VEGF as chemoattractant), adhesion capacity (on fibronectin-coated culture dishes) and ROS production (ROS-sensitive fluorescent probe CM-H2DCFDA).ResultsMACs obtained from diabetic individuals with high HDL-C had 23% higher viability compared to low HDL-C (111.6 ± 32.7% vs. 90.5 ± 28.6% optical density; p = 0.002). H2O2 exposure impaired MACs viability to a similar extent in both groups (109.2 ± 31.7% vs. 74.5 ± 40.8% in high HDL-C, p < 0.0001; 88.3 ± 25.5% vs. 72.3 ± 22.5% in low-HDL, p = 0.004). MACs senescence was comparable in the two groups (102.7 ± 29.8% vs. 99.2 ± 27.8%; p = 0.703) and was only slightly modified by exposure to H2O2. There was no difference in the MACs migration capacity between the two groups (91.3 ± 34.2% vs. 108.7 ± 39.5%; p = 0.111), as well as in MACs adhesion capacity (105.2 ± 32.7% vs. 94.1 ± 26.1%; p = 0.223). Finally, ROS production was slightly thought not significantly higher in MACs from type 2 diabetes individuals with low- than high-HDL. After stratification of HDL-C levels into quartiles, viability (p < 0.0001) and adhesion (p = 0.044) were higher in Q4 than in Q1–Q3. In logistic regression analysis, HDL-C was correlated to MACs viability and adhesion independently of HbA1c or BMI, respectively.ConclusionsOur data suggest that in type 2 diabetes subjects, HDL-cholesterol is an independent determinant of circulating MACs functional capacities—mainly viability, to a lesser extent adhesion—likely contributing also through this mechanism to cardiovascular protection even in type 2 diabetes.

HDL of Patients with Type 2 Diabetes Mellitus Elevates the Capability of Promoting Breast Cancer Metastasis.

High-density Lipoprotein of Patients with Breast Cancer Complicated with Type 2 Diabetes Mellitus Promotes Cancer Cells Adhesion to Vascular Endothelium Via ICAM-1 and VCAM-1 Upregulation

Hdl Cholesterol and Cancer Risk among Patients with Type 2 Diabetes

Hypochlorite-induced Oxidative Stress Elevates the Capability of HDL in Promoting Breast Cancer Metastasis

Effects of diabetic HDL on endothelial cell function.

Glycation of High-Density Lipoprotein Triggers Oxidative Stress and Promotes the Proliferation and Migration of Vascular Smooth Muscle Cells

Impact of Diabetes on Promoting the Growth of Breast Cancer

Association of carbamylated high-density lipoprotein with coronary artery disease in type 2 diabetes mellitus: carbamylated high-density lipoprotein of patients promotes monocyte adhesion

Effects of High-Density Lipoprotein and Lipoprotein-Deficient Serum on Intracellular Cholesterol Efflux in Patients with Type 2 Diabetes Mellitus

The increased antioxidant action of HDL is independent of HDL cholesterol plasma levels in triple-negative breast cancer

HDL in Diabetic Nephropathy Has Less Effect in Endothelial Repairing Than Diabetes Without Complications.

Influence of high density lipoprotein cholesterol levels on circulating monocytic angiogenic cells functions in individuals with type 2 diabetes mellitus

Diabetes-Invoked High-Density Lipoprotein and Its Association with Coronary Artery Disease in Patients with Type 2 Diabetes Mellitus.

Abstract B76: High Glucose Induces Breast Cancer Progression Through Upregulating PP2Cδ

Correlation of breast cancer and abnormal high-density lipoprotein-cholesterol level: a Meta-analysis

Diabetic HDL is Dysfunctional in Stimulating Endothelial Cell Migration and Proliferation Due to Down Regulation of SR-BI Expression.

Characteristics of HDL2b Changes and Their Significance in Prediction of Risks for Coronary Artery Disease in Type 2 Diabetic Patients

HDL Improves Cholesterol and Glucose Homeostasis and Reduces Atherosclerosis in Diabetes-Associated Atherosclerosis

High-density Lipoprotein of Patients with Type 2 Diabetes Mellitus Upregulates Cyclooxgenase-2 Expression and Prostacyclin I-2 Release in Endothelial Cells: Relationship with HDL-associated Sphingosine-1-phosphate

Clinical features and molecular phenotypes of breast cancer in patients with type-2 diabetes mellitus.

Changes of HDL Level, Structure and Function in Type 2 Diabetes Mellitus Patients and Its Relationship with Atherosclerotic Cardiov Asc Ular Disease